Recurrent Hairy Cell Leukemia Variant
2 clinical trials · Condition
◉ Watch Recurrent Hairy Cell Leukemia Variant
| Record | Firm | Date |
|---|---|---|
| Ibrutinib in Treating Patients With Relapsed Hairy Cell Leukemia (NCT01841723) | National Cancer Institute (NCI) | 2013-04-30 |
Track Recurrent Hairy Cell Leukemia Variant automatically
Every clearance here is in the API, with alerts when new ones post.